Effect of PEGylation on biodistribution and gene silencing of siRNA/lipid nanoparticle complexes

Yanjie Bao, Yi Jin, Padmanabh Chivukula, Jun Zhang, Yun Liu, Jian Liu, Jean Pierre Clamme, Ram I. Mahato, Dominic Ng, Wenbin Ying, Yiting Wang, Lei Yu

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Purpose: To determine the influence of physicochemical properties of lipid nanoparticles (LNPs) carrying siRNA on their gene silencing in vivo. Mechanistic understanding of how the architecture of the nanoparticle can alter gene expression has also been studied. Methods: The effect of 3-N-[(ω- methoxypoly(ethylene glycol)2000)carbamoyl]-1,2-dimyristyloxy-propylamine (PEG-C-DMA) on hepatic distribution and FVII gene silencing was determined. FVII mRNA in hepatocytes and liver tissues was determined by Q-PCR. Hepatic distribution was quantified by FACS analysis using Cy5 labeled siRNA. Results: Gene silencing was highly dependent on the amount of PEG-C-DMA present. FVII gene silencing inversely correlated to the amount of PEG-C-DMA in LNPs. High FVII gene silencing was obtained in vitro and in vivo when the molar ratio of PEG-C-DMA to lipid was 0.5 mol%. Surprisingly, PEGylation didn't alter the hepatic distribution of the LNPs at 5 h post administration. Instead the amount of PEG present in the LNPs has an effect on red blood cell disruption at low pH. Conclusion: Low but sufficient PEG-C-DMA amount in LNPs plays an important role for efficient FVII gene silencing in vivo. PEGylation did not alter the hepatic distribution of LNPs, but altered gene silencing efficacy by potentially reducing endosomal disruption.

Original languageEnglish (US)
Pages (from-to)342-351
Number of pages10
JournalPharmaceutical Research
Volume30
Issue number2
DOIs
StatePublished - Feb 1 2013

Fingerprint

Gene Silencing
Nanoparticles
Small Interfering RNA
Polyethylene glycols
Genes
Dynamic mechanical analysis
Lipids
Liver
Ethylene Glycol
Gene expression
Hepatocytes
Blood
Erythrocytes
Cells
poly(ethylene glycol)-dimethacrylate
Tissue
Gene Expression
Polymerase Chain Reaction
Messenger RNA

Keywords

  • FVII
  • LNP
  • PEG-C-DMA
  • endosomal disruption
  • gene silencing
  • hepatic distribution

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)

Cite this

Effect of PEGylation on biodistribution and gene silencing of siRNA/lipid nanoparticle complexes. / Bao, Yanjie; Jin, Yi; Chivukula, Padmanabh; Zhang, Jun; Liu, Yun; Liu, Jian; Clamme, Jean Pierre; Mahato, Ram I.; Ng, Dominic; Ying, Wenbin; Wang, Yiting; Yu, Lei.

In: Pharmaceutical Research, Vol. 30, No. 2, 01.02.2013, p. 342-351.

Research output: Contribution to journalArticle

Bao, Y, Jin, Y, Chivukula, P, Zhang, J, Liu, Y, Liu, J, Clamme, JP, Mahato, RI, Ng, D, Ying, W, Wang, Y & Yu, L 2013, 'Effect of PEGylation on biodistribution and gene silencing of siRNA/lipid nanoparticle complexes', Pharmaceutical Research, vol. 30, no. 2, pp. 342-351. https://doi.org/10.1007/s11095-012-0874-6
Bao, Yanjie ; Jin, Yi ; Chivukula, Padmanabh ; Zhang, Jun ; Liu, Yun ; Liu, Jian ; Clamme, Jean Pierre ; Mahato, Ram I. ; Ng, Dominic ; Ying, Wenbin ; Wang, Yiting ; Yu, Lei. / Effect of PEGylation on biodistribution and gene silencing of siRNA/lipid nanoparticle complexes. In: Pharmaceutical Research. 2013 ; Vol. 30, No. 2. pp. 342-351.
@article{d368c5b2741545eca93f10c8a526a3c7,
title = "Effect of PEGylation on biodistribution and gene silencing of siRNA/lipid nanoparticle complexes",
abstract = "Purpose: To determine the influence of physicochemical properties of lipid nanoparticles (LNPs) carrying siRNA on their gene silencing in vivo. Mechanistic understanding of how the architecture of the nanoparticle can alter gene expression has also been studied. Methods: The effect of 3-N-[(ω- methoxypoly(ethylene glycol)2000)carbamoyl]-1,2-dimyristyloxy-propylamine (PEG-C-DMA) on hepatic distribution and FVII gene silencing was determined. FVII mRNA in hepatocytes and liver tissues was determined by Q-PCR. Hepatic distribution was quantified by FACS analysis using Cy5 labeled siRNA. Results: Gene silencing was highly dependent on the amount of PEG-C-DMA present. FVII gene silencing inversely correlated to the amount of PEG-C-DMA in LNPs. High FVII gene silencing was obtained in vitro and in vivo when the molar ratio of PEG-C-DMA to lipid was 0.5 mol{\%}. Surprisingly, PEGylation didn't alter the hepatic distribution of the LNPs at 5 h post administration. Instead the amount of PEG present in the LNPs has an effect on red blood cell disruption at low pH. Conclusion: Low but sufficient PEG-C-DMA amount in LNPs plays an important role for efficient FVII gene silencing in vivo. PEGylation did not alter the hepatic distribution of LNPs, but altered gene silencing efficacy by potentially reducing endosomal disruption.",
keywords = "FVII, LNP, PEG-C-DMA, endosomal disruption, gene silencing, hepatic distribution",
author = "Yanjie Bao and Yi Jin and Padmanabh Chivukula and Jun Zhang and Yun Liu and Jian Liu and Clamme, {Jean Pierre} and Mahato, {Ram I.} and Dominic Ng and Wenbin Ying and Yiting Wang and Lei Yu",
year = "2013",
month = "2",
day = "1",
doi = "10.1007/s11095-012-0874-6",
language = "English (US)",
volume = "30",
pages = "342--351",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Effect of PEGylation on biodistribution and gene silencing of siRNA/lipid nanoparticle complexes

AU - Bao, Yanjie

AU - Jin, Yi

AU - Chivukula, Padmanabh

AU - Zhang, Jun

AU - Liu, Yun

AU - Liu, Jian

AU - Clamme, Jean Pierre

AU - Mahato, Ram I.

AU - Ng, Dominic

AU - Ying, Wenbin

AU - Wang, Yiting

AU - Yu, Lei

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Purpose: To determine the influence of physicochemical properties of lipid nanoparticles (LNPs) carrying siRNA on their gene silencing in vivo. Mechanistic understanding of how the architecture of the nanoparticle can alter gene expression has also been studied. Methods: The effect of 3-N-[(ω- methoxypoly(ethylene glycol)2000)carbamoyl]-1,2-dimyristyloxy-propylamine (PEG-C-DMA) on hepatic distribution and FVII gene silencing was determined. FVII mRNA in hepatocytes and liver tissues was determined by Q-PCR. Hepatic distribution was quantified by FACS analysis using Cy5 labeled siRNA. Results: Gene silencing was highly dependent on the amount of PEG-C-DMA present. FVII gene silencing inversely correlated to the amount of PEG-C-DMA in LNPs. High FVII gene silencing was obtained in vitro and in vivo when the molar ratio of PEG-C-DMA to lipid was 0.5 mol%. Surprisingly, PEGylation didn't alter the hepatic distribution of the LNPs at 5 h post administration. Instead the amount of PEG present in the LNPs has an effect on red blood cell disruption at low pH. Conclusion: Low but sufficient PEG-C-DMA amount in LNPs plays an important role for efficient FVII gene silencing in vivo. PEGylation did not alter the hepatic distribution of LNPs, but altered gene silencing efficacy by potentially reducing endosomal disruption.

AB - Purpose: To determine the influence of physicochemical properties of lipid nanoparticles (LNPs) carrying siRNA on their gene silencing in vivo. Mechanistic understanding of how the architecture of the nanoparticle can alter gene expression has also been studied. Methods: The effect of 3-N-[(ω- methoxypoly(ethylene glycol)2000)carbamoyl]-1,2-dimyristyloxy-propylamine (PEG-C-DMA) on hepatic distribution and FVII gene silencing was determined. FVII mRNA in hepatocytes and liver tissues was determined by Q-PCR. Hepatic distribution was quantified by FACS analysis using Cy5 labeled siRNA. Results: Gene silencing was highly dependent on the amount of PEG-C-DMA present. FVII gene silencing inversely correlated to the amount of PEG-C-DMA in LNPs. High FVII gene silencing was obtained in vitro and in vivo when the molar ratio of PEG-C-DMA to lipid was 0.5 mol%. Surprisingly, PEGylation didn't alter the hepatic distribution of the LNPs at 5 h post administration. Instead the amount of PEG present in the LNPs has an effect on red blood cell disruption at low pH. Conclusion: Low but sufficient PEG-C-DMA amount in LNPs plays an important role for efficient FVII gene silencing in vivo. PEGylation did not alter the hepatic distribution of LNPs, but altered gene silencing efficacy by potentially reducing endosomal disruption.

KW - FVII

KW - LNP

KW - PEG-C-DMA

KW - endosomal disruption

KW - gene silencing

KW - hepatic distribution

UR - http://www.scopus.com/inward/record.url?scp=84873418330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873418330&partnerID=8YFLogxK

U2 - 10.1007/s11095-012-0874-6

DO - 10.1007/s11095-012-0874-6

M3 - Article

C2 - 22983644

AN - SCOPUS:84873418330

VL - 30

SP - 342

EP - 351

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 2

ER -